Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Dynorphin 1-13 on Heroin Addiction

NCT00000244 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT00000244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00000244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Dynorphin 1-13 on Heroin Addiction
Lead sponsor
University of Minnesota
Phase
Phase 2
Overall status
Completed
Start date
August 31, 1994
Completion date
March 31, 1997
Enrollment
0
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid-related disorders, substance withdrawal syndrome